Indoloprodigiosins from the C-10 bipyrrolic precursor: New antiproliferative prodigiosin analogs

Synthesis, Structure, Spectral, Electrochemical, and Theoretical Studies of Ru(II) Complexes of 3-Pyrrolyl BODIPY-Based Ligands

3-Pyrrolyl BODIPY having an appended pyrrolyl group at the 3-position of BODIPY (4,4-difluoro-4-bora-3a,4a-diaza-s-indacene) and its functionalized derivatives have been used as ligands to prepare one example of Ru(II) complex of pyrrolyl dipyrrin and three unique examples of bichromophoric BODIPY-Ru(II) complexes in good yields. The complexes were characterized by HR-MS, 1D and 2D NMR, X-ray analysis for two complexes, absorption, cyclic voltammetry, and DFT/TD-DFT techniques. The X-ray structure of the Ru(II) complex of pyrrolyl dipyrrin revealed that the geometry around the Ru(II) ion was pseudo-octahedral with an arene unit occupying three coordination sites in η6-fashion and two nitrogen atoms of the dipyrrin ring and one chloro group adopting the "three legs piano-stool" structure. The X-ray structure of the bichromophoric BODIPY-Ru(II) complex revealed that the BODIPY core was planar and the central B(III) was coordinated with two pyrrole nitrogens of the dipyrrin unit and two axial fluoride ions in a tetrahedral geometry, and Ru(II) was bonded to appended pyrrole "N" and "N" of benzimidazole substituent present at the α-position of appended pyrrole, one chloro group, and one arene ring in a pseudo-octahedral geometry. The spectral studies revealed that the electronic properties of the BODIPY unit in BODIPY-Ru(II) complexes were significantly altered, and electrochemical studies indicated that the BODIPY-Ru(II) complexes exhibit one oxidation corresponding to Ru(II) to Ru(III) and one reduction corresponding to the BODIPY unit. The DFT/TD-DFT studies corroborated the experimental observations.

Synthesis, Anticancer Potential and Comprehensive Toxicity Studies of Novel Brominated Derivatives of Bacterial Biopigment Prodigiosin from Serratia marcescens ATCC 27117

Prodigiosins (prodiginines) are a class of bacterial secondary metabolites with remarkable biological activities and color. In this study, optimized production, purification, and characterization of prodigiosin (PG) from easily accessible Serratia marcescens ATCC 27117 strain has been achieved to levels of 14 mg/L of culture within 24 h. Furthermore, environmentally friendly bromination of produced PG was used to afford both novel mono- and dibrominated derivatives of PG. PG and its Br derivatives showed anticancer potential with IC₅₀ values range 0.62–17.00 µg/mL for all tested cancer cell lines and induction of apoptosis but low selectivity against healthy cell lines. All compounds did not affect Caenorhabditiselegans at concentrations up to 50 µg/mL. However, an improved toxicity profile of Br derivatives in comparison to parent PG was observed in vivo using zebrafish (Danio rerio) model system, when 10 µg/mL applied at 6 h post fertilization caused death rate of 100%, 30% and 0% by PG, PG-Br, and PG-Br_2, respectively, which is a significant finding for further structural optimizations of bacterial prodigiosins. The drug-likeness of PG and its Br derivatives was examined, and the novel Br derivatives obey the Lipinski’s “rule of five”, with an exemption of being more lipophilic than PG, which still makes them good targets for further structural optimization.

Study on the Anticancer Activity of Prodigiosin from Variants of Serratia Marcescens QBN VTCC 910026

Prodigiosin (Pg), a secondary metabolism produced by numerous bacterial species, is known as anticancer, antibacterial, antifungal, immunosuppressant, antioxidant, antimalarial properties. Pg has been tested for antitumor activity in many different cancer cell lines but studies in LU-1, KB cell lines, and tumor-bearing mice are still limited. In this study, Serratia marcescens QBN VTCC 910026 strain (GenBank: KX674054.1) was mutated using Ethyl Methanesulfonate (EMS) to increase the production of Pg. One strain known as EMS 5 was capable of increasing prodigiosin biosynthetic yield by 52% when compared to the wild-type strain. Red bacterial pigmented colonies containing Pg were collected from solid media, lysed with acetone, purified with toluene: ethyl acetate at a ratio of 9: 1 (v/v), and then used to evaluate the potential anticancer activity. The purity of Pg was confirmed using a high-performance liquid chromatography (HPLC) method which indicated a 98% rate. Pg chemical formula which was determined using 1H-NMR and 13C-NMR spectroscopy, confirmed as prodigiosin (Pg). Human breast cancer cell lines MCF-7, oropharyngeal cancer KB, and particularly lung cancer LU-1 in vitro were used to test the anticancer activity of purified Pg compound. It showed a strong inhibitory ability in all the cancer cell lines. Furthermore, the isolated Pg had capable of inhibiting tumor growth, the tumor volume decreased by 36.82%, after 28 days. The results indicated that the bacterial prodigiosin from variants Serratia marcescens QBN VTCC 910026 strain is an encouraging fragment suitable for therapeutic applications.

Preparation of Cyclic Prodiginines by Mutasynthesis in Pseudomonas putida KT2440

Prodiginines are a group of naturally occurring pyrrole alkaloids produced by various microorganisms and known for their broad biological activities. The production of nature-inspired cyclic prodiginines was enabled by combining organic synthesis with a mutasynthesis approach based on the GRAS (generally recognized as safe) certified host strain Pseudomonas putida KT2440. The newly prepared prodiginines exerted antimicrobial effects against relevant alternative biotechnological microbial hosts whereas P. putida itself exhibited remarkable tolerance against all tested prodiginines, thus corroborating the bacterium's exceptional suitability as a mutasynthesis host for the production of these cytotoxic secondary metabolites. Moreover, the produced cyclic prodiginines proved to be autophagy modulators in human breast cancer cells. One promising cyclic prodiginine derivative stood out, being twice as potent as prodigiosin, the most prominent member of the prodiginine family, and its synthetic derivative obatoclax mesylate.

Prodigiosin and its potential applications

Since a decade, there has been a strong consumer demand for more natural products. This has augmented inclination towards substitution of synthetic colorants with natural pigments. Natural pigments not only have the capacity to increase the marketability of products, they also demonstrate valuable biological activities as antioxidants and anticancer agents. There is a long history of exploitation of natural products produced by bacteria as sources of pharmaceutically important, bioactive compounds. Among natural pigments, pigments from microbial sources are potentially suitable alternatives to synthetic pigments. The red pigment prodigiosin (PG) has unusual properties, which have long been documented. The red-pigmented prodiginines are bioactive secondary metabolites produced by both Gram-negative and Gram-positive bacteria. Prodigiosins are characterized by a common pyrrolyl pyrromethene skeleton, and the biological role of these pigments in the producer organisms remains unclear. Bacterial prodigiosins and their synthetic derivatives are effective proapoptotic agents against various cancer cell lines, with multiple cellular targets including multi-drug resistant cells with little or no toxicity towards normal cell lines. However, research into the biology of pigment production will stimulate interest in the bioengineering of strains to synthesize useful prodiginine derivatives. This review article highlights the characteristics and potential applications of prodigiosin pigment from Serratia as prodigiosins are real potential therapeutic drugs.

Prodigiosin alkaloids: recent advancements in total synthesis and their biological potential

The present review article is focused on the medicinal potential and total synthesis of prodigiosins witnessed in the last decade. The aim will be to provide an inspiration to the marvels and pit falls of constructing the polypyrrole heterocycles with in the complex systems.

Antimicrobial activity of prodigiosin isolated from Serratia marcescens UFPEDA 398

Prodigiosin is an alkaloid and natural red pigment produced by Serratia marcescens. Prodigiosin has antimicrobial, antimalarial and antitumor properties and induces apoptosis in T and B lymphocytes. These properties have piqued the interest of researchers in the fields of medicine, pharmaceutics and different industries. The aim of the present study was to evaluate the antimicrobial activity of prodigiosin against pathogenic micro-organisms. The red pigments produced by S. marcescens exhibited absorption at 534 nm, Rf of 0.59 and molecular weight of 323 m/z. Antimicrobial activity was tested against oxacillin-resistant Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Enterococcus faecalis, Streptococcus pyogenes, Acinetobacter sp. and oxacillin-resistant S. aureus. The standard antibiotics employed were ampicillin, chloramphenicol, gentamicin and oxacillin. The disc-diffusion tests demonstrated significant inhibition zones for S. aureus (35 ± 0.6), E. faecalis (22 ± 1.0) and S. pyogenes (14 ± 0.6). However, prodigiosin showed resistance to E. coli, P. aeruginosa and acinetobacter, where no significant formation of inhibitory halos were observed. We determined the inhibitory minimum concentrations and bactericidal for 20 strains of oxacillin-resistant S. aureus (ORSA). The pattern was the antibiotic oxacillin. The minimum inhibitory concentrations observed ranged from 1, 2 and 4.0 μg/mL, respectively, while the minimum bactericidal concentrations ranged from 2, 4, 8 and 16 μg/mL. The S. marcescens prodigiosin produced by showed bactericidal and bacteriostatic effect showing promising antimicrobial activity and suggesting future studies regarding its applicability in antibiotics therapies directed ORSA.

Undecylprodigiosin induced apoptosis in P388 cancer cells is associated with its binding to ribosome

Prodigiosins (PGs) are a family of natural red pigments with anticancer activity, and one member of the family has entered clinical phase II trials. However, the anticancer mechanisms of PGs remain largely unclear. This study was designed to investigate the molecular basis of anticancer activity of UP, a derivative of PGs, in P388 cells. By introducing pharmacological inhibitors and utilizing a variety of analytical approaches including western blotting, flow cytometry and confocal laser microscopy, we found that UP inhibited proliferation of P388 via arresting cells at G2/M phase and inducing cells apoptosis, which was related to the activation of P38, JNK rather than ERK1/2 signaling. ROS regeneration and acidification in cells appear not involved in UP induced apoptosis. Furthermore, utilizing mass spectrometry, sucrose density gradient fractionation and immunofluorescence staining, we discovered that UP was apparently located at ribosome. These results together indicate that ribosome may be the potential target of UP in cancer cells, which opened a new avenue in delineating the anticancer mechanism of PGs.

Investigations regarding the utility of prodigiosenes to treat leukemia

Prodigiosenes, possessing a 4-methoxypyrrolyldipyrrin skeleton, are known for their anti-cancer activity. Structural modification of the C-ring resulted in a series of prodigiosenes that displayed promising activity against leukemia cell lines during in vitro analysis against the NCI 60 cancer cell line panel. Further in vivo studies of these compounds using the zebrafish model showed persistence of anti-leukemia properties in human K562 chronic myelogenous leukemia cells.

Prodigiosin synthesis with electron rich 2,2′-bipyrroles

The prodigiosins possess a linear tripyrrolic scaffold with the A and B pyrrolic rings connected directly in a bipyrrole unit, and the B and C rings joined in a dipyrrin. These red streptomycete metabolites exhibit among other activities, antitumor, antimicrobial, and immunomodulating properties. A new prodigiosin synthesis has been developed that employs electron rich 2,2′-bipyrroles. In particular, undecylprodigiosin and PNU-156804 were synthesized by condensations of 4-methoxy and 4-benzyloxy 2,2′-bipyrroles, 20a and 20b, respectively, with 5-undecylpyrrole-2-carboxaldehyde in 75% and 83% yields. The 4-alkoxy-2,2′-bipyrroles were synthesized from 4-alkoxypyrrolyl butenyl ketones (15a and 15b), which were made by a novel one-pot process from 2-acyl-N-(PhF)pyrrolidin-4-one (13) [PhF = 9-(9-phenylfluorenyl)] using PhFNa in the presence of alkyl halide. A sequence of alkoxy pyrrole 15a and 15b protection, olefin oxidation, Paal–Knorr condensation, and deprotection gave the requisite 4-alkoxy-2,2′-bipyrroles (20). This route offers utility for making 4-alkoxybipyrroles as well as prodigiosins with diversity at the 6-position of the linear tripyrrolic skeleton.Key words: prodigiosin, pyrrole, bipyrrole, PNU-156804, undecylprodigiosin.

Anticancer and immunosuppressive properties of bacterial prodiginines

Bacterial prodiginines are a family of red-pigmented, tripyrrolic compounds that display numerous biological activities, including antibacterial, antifungal, antiprotozoal, antimalarial, immunosuppressive and anticancer properties. Recently, significant progress has been made in understanding the biosynthesis and regulation of bacterial prodiginines. An understanding of the biosynthesis of prodiginines will allow engineering of bacterial strains capable of synthesizing novel prodiginines through rational design and mutasynthesis experiments. Bacterial prodiginines and synthetic derivatives are effective proapoptotic agents with multiple cellular targets, and they are active against numerous cancer cell lines, including multidrug-resistant cells, with little or no toxicity towards normal cell lines. A synthetic derivative, GX15-070 (Obatoclax), developed through structure-activity relationship studies of the pyrrolic ring A of GX15, is in multiple Phase I and II clinical trials in both single and dual-agent studies to treat different types of cancer. Therefore, prodiginines have real therapeutic potential in the clinic.

Tautomeric equilibria in phenolic A-ring derivatives of prodigiosin natural products

The prodigiosin natural products contain a common 4-methoxy-pyrromethene chromophore that is attached to a pyrrole A-ring that has its lone-pair nitrogen electrons in conjugation with the pyrromethene entity. This feature is known to play a key role in the biological activities (anticancer, antimicrobial, and immunosuppressive) of the prodigiosins. In an attempt to alter or improve upon the therapeutic potential of the prodigiosins, we have synthesized two new isomeric analogues that contain phenolic A-ring systems (a para (p)-phenol; an ortho (o)-phenol with respect to the pyrromethene) with lone-pair oxygen electrons in conjugation with the pyrromethene chromophore of the natural product. Herein, we report on the optical properties of the phenolic prodigiosin analogues that have been measured using absorbance and steady-state emission spectroscopy. For both analogues absorption measurements in aprotic solvents show that the neutral (L) ligands exist as the enol tautomers with lambda(max) ~ 460 nm, as noted for the parent prodigiosin natural product. However, in polar protic solvents the phenolic derivatives undergo ground-state prototropic tautomerization to generate keto tautomers with lambda(max) ~ 530 nm. This unique feature for a prodigiosin analogue involves proton transfer from the phenolic OH to the pyrromethene N1 proton acceptor atom. Tautomeric equilibrium constants (KT) of 1.4 in 1:4 MeCN/H2O (v/v) have been determined from examination of the absorption spectra. Titration of the o-phenolic derivative with Zn(II) in methanol yielded a 40-fold increase in fluorescence intensity (lambda(max) 542 nm) and generated a new 1:1 complex with Zn(II) with a log K of 5.29, suggesting the potential utility of this analogue to act as a fluorescence probe in a biological matrix to monitor Zn(II) concentrations. Our results demonstrate that phenolic A-ring derivatives of prodigiosins possess some unique properties that may act to enhance the biological properties of the prodigiosin natural products.

Synthesis and Anti-Cancer Activity of C-Ring-Functionalized Prodigiosin Analogues

Prodigiosin is the parent member of the 4-methoxypyrrolyldipyrromethene family of natural products and is known for its anti-cancer activity. A new series of analogues was synthesized, incorporating pendent functional esters and beta-carbonyl substituents on the C-ring. The beta-carbonyl group allowed for the facile isolation of the prodigiosenes, and the pendent esters allow for further derivatization. The novel prodigiosenes generally retain the anti-cancer activity of prodigiosin in 60 human cell lines derived from nine cancer cell types, with neither the conjugated beta-carbonyl group, as either ketone or ester, nor the pendent ester significantly reducing the anti-cancer activity of the core skeleton.

Total Synthesis, Molecular Editing and Evaluation of a Tripyrrolic Natural Product: The Case of “Butylcycloheptylprodigiosin”

Conflicting reports are found in the literature on whether the ortho-pyrrolophane derivative 6, which has been named "butylcycloheptylprodigiosin" even though it is a cyclononane derivative, is a natural product or merely a mis-assigned structure. This dispute has now been resolved by an unambiguous total synthesis of this complex alkaloid which confirms the initial structure assignment. The chosen approach is largely catalysis-based, featuring the first application of a "Narasaka-Heck" reaction in natural product chemistry. This palladium-catalyzed transformation allows the unsaturated oxime ester 26 to be converted into the bicyclic dihydropyrrole 27. Other notable reactions of the reported approach to 6 are a regioselective Tsuji-Trost reaction of the doubly allylic acetate 21 with methyl acetoacetate, a base-induced aromatization of 27 to the corresponding pyrrole 28, a chemoselective oxidation of the benzylic methyl group in 33 with cerium ammonium nitrate in a biphasic reaction medium that does not affect the labile pyrrole nucleus, and a Suzuki cross-coupling for the completion of the heterocyclic domain. Diversification in the latter step leads to a set of analogues that differ from the natural product in the terminal (hetero)arene ring. This structural modification results in complete loss of the very pronounced ability of the parent compound 6 to induce oxidative cleavage in double stranded DNA in the presence of Cu(II). Several cyclononane-, cyclononene- and cyclononadiene derivatives prepared en route to 6 have been characterized by crystal structure analysis, allowing the conformational behavior of nine-membered carbocycles to be studied.

Chloride anion transport and copper-mediated DNA cleavage by C-ring functionalized prodigiosenes

A new class of prodigiosenes with stability-enhancing functionalities appended to the C-ring were found to transport chloride anions through liposomal membranes, as well as to induce copper-mediated DNA cleavage.

Photoinduced Cytotoxicity and Thioadduct Formation by a Prodigiosin Analogue

[reaction: see text] The prodigiosin alkaloid 1 and the synthetic analogue 2 show photoinduced cytotoxicity against HL-60 cancer cells. Photoirradiation of 1 and 2 causes photofading, photooxidation, and thioadduct formation. These results provide a model for the redox properties of prodigiosins that play a role in their biological activity and provide a new way to functionalize their pyrromethene entity with water-soluble thiol groups.